Emkay recommends `Reduce` on Ranbaxy
Emkay has recommended `Reduce` on Ranbaxy with a price target of Rs 395 as against the market price of Rs 458 in its report dated May 12, 2010.
Ranbaxy has announced that its chief executive officer and managing director Dr Atul Sobti is to step down from the positions later this month.